Status:

COMPLETED

Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) Study

Lead Sponsor:

Ewha Womans University Mokdong Hospital

Conditions:

Nonalcoholic Fatty Liver

Nonalcoholic Steatohepatitis

Eligibility:

All Genders

19-75 years

Phase:

NA

Brief Summary

Several diets have been proposed to reduce liver steatosis in patients with nonalcoholic fatty liver disease (NAFLD), and various effects on liver steatosis have been observed. The objective of this t...

Detailed Description

This is an open-label randomised controlled trial of patients with NAFLD. Patients are recruited in the Liver Outpatient Clinic of the Ewha Womans University Mokdong Hospital. The department of Nutrit...

Eligibility Criteria

Inclusion

  • NAFLD diagnosed by (1) Histologic assessment with a fat accumulation of more than 5% of the liver's weight in a biopsy, or (2) Radiologic assessment with a MRI-PDFF ≥8%.
  • Age between 19 and 75 years
  • Capability to understand the study and the individual consequences of participation
  • Signed and dated declaration of agreement in the forefront of the study

Exclusion

  • Daily alcohol consumption \>30 g in men and \>20 g in women
  • Other causes of chronic liver disease (HBV, HCV, HDV, HEV, HIV), autoimmune diseases or chronic cholestatic liver disease, drug induced liver injury, hereditary haemochromatosis, Wilson disease, α-1-Antitrypsin deficiency
  • Liver cirrhosis
  • Hepatocellular carcinoma
  • Medications which cause liver disease or secondary NAFLD (e.g. Tamoxifen, systemic Corticosteroids, Methotrexate, Tetracycline, Estrogens, Valproic acid)
  • Changes in body weight \> 5% in the last 3 months
  • Intake of medical treatment for NAFLD/NASH in the last 6 months (except for vitamin E)
  • Diabetes
  • Pregnancy
  • Patients after organ transplantations
  • Missing or lacking consent capability

Key Trial Info

Start Date :

March 7 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 6 2023

Estimated Enrollment :

72 Patients enrolled

Trial Details

Trial ID

NCT05309642

Start Date

March 7 2022

End Date

December 6 2023

Last Update

February 20 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ewha Womans University College of Medicine

Seoul, Yangcheon-gu, South Korea, 07985